Any wound that remains unhealed after 4 weeks is cause for concern, as it is associated with worse outcomes, including amputations.1 Make the shift to Dermagraft for faster healing times with clinically proven results.2  Learn More

1. American Diabetes Association. Consensus development conference on diabetic foot wound care, 7-8 April 1999, Boston Massachusetts. Diabetes Care. 1999;22:1354-1360
2. Marston et al. The efficacy and safety of Dermagraft inimproving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care. 2003;26(6):1701-1705.

Dermagraft Directions for Use

DFUIntended Use/Indications
Dermagraft is indicated for use in the treatment of full-thickness diabetic foot ulcers greater than six weeks duration, which extend through the dermis, but without tendon, muscle, joint capsule, or bone exposure. Dermagraft should be used in conjunction with standard wound care regimens and in patients that have adequate blood supply to the involved foot.
Learn More

Contraindications
Dermagraft is contraindicated for use in ulcers that have signs of clinical infection or in ulcers with sinus tracts. Dermagraft is contraindicated in patients with known hypersensitivity to bovine products, as it may contain trace amounts of bovine proteins from the manufacturing medium and storage solution.
Learn More

Featured Video

Content Container - Featured Video (Home)Dermagraft provides a combination of living fibroblasts, matrix proteins, and bound factors that protect the wound and stimulate dynamic events that promote regeneration and repair. Click “Learn More” to view animations about how Dermagraft is made and how it assists in the healing process.
Learn More